Delivery Order SPE2DB22D2206-SPE2DB24FFK72
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,900.16 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,483.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order is set to be completed by February 22, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical product. The $3,744.16 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract with a potential value of $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency (DLA) to provide the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The award has a potential value of $1,161.08 and a performance period through February 21, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of $3,483.24 worth of OZEMPIC 0.25-0.5MG 1S pharmaceutical products. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $7,327.60 to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract and there is no set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an indefinite...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,966.48 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $21,480.91 by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...